Cerebrospinal fluid prostate specific antigen (CSF PSA) in prostate cancer patients with lower spine metastasis

International Urology and Nephrology

Volumn 37, Issue 4, 2005, Pages 727-730

  Şahin, Hayrettin ^a   Aflay, Uǧur ^a   Batun, Sabri ^a   Bircan, Mehmet Kamuran ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Cerebrospinal fluid; Prostate cancer; Prostate specific antigen

Indexed keywords

GONADORELIN DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; MALE; ORCHIECTOMY; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RANK SUM TEST; SPINAL ANESTHESIA; SPINE METASTASIS; STATISTICAL SIGNIFICANCE; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; CHEMILUMINESCENT MEASUREMENTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SPINAL NEOPLASMS;

EID: 31144441651     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-005-8438-x     Document Type: Article

References (14)

1. Bjartell A, Bjork T, Matikainen MT et al. Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium Urology 1993; 42(5): 502-510. 10.1016/0090-4295(93)90259-D 7694414 1:STN:280:ByuD2MvotlA%3D A1993MG84900002
2. Lilja H, Piironen TP, Rittenhouse HG et al. Prostate Spesific Antigen. In: Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds) Genitourinary Oncoloy. 2nd Lippicot Williams & Wilkins, Philadelphia 2000, pp 638-640.
3. Oesterling JE. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate J Urol 1991; 145(5) 907-923. 1707989 1:STN:280:By6B3c3ms1c%3D
4. Spitz J, Enzmann T, Muller W et al. Estimation of total PSA with a supersensitive PSA-assay during neo-adjuvant-chemotherapy of prostate cancer before radical resection of prostate Anticancer Res 1999 19(4A): 2637-2640. 10470209 1:CAS:528:DyaK1MXlvVCmsbY%3D 000082106200046
5. Yu H. Clinical implications of prostate-specific antigen in men and women. J Gend Specif Med 2000; 3(2): 45-853 11253246 1:STN:280:DC%2BD3M3hsF2nsA%3D%3D
6. Wolff JM, Borchers H, Kunitz O et al. Prostate-specific antigen immunoreactivity in spinal fluid. Urol Int 1997; 59(4): 236-238. 9444741 1:CAS:528:DyaK1cXltVarug%3D%3D
7. Geldof AA. Models for cancer skeletal metastasis: A reappraisal of Batson's plexus Anticancer Res 1997; 17(3A): 1535-1539. 9179192 1:STN:280:ByiA383ntVY%3D A1997XB41600013
8. Morote J, Ruibel A, Boada M. Behaviour of prostatic spesific antigen in spinal fluid: Its correlation with serum levels. Int J Biol Markers 1986; 1: 109-110. 2448396 1:STN:280:BieC3MnptVU%3D
9. McCormack RT, Rittenhouse HG, Finlay JA et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era. Urology 1998; 45: 729-744. 10.1016/S0090-4295(99)80076-4 7538236 1:STN:280:ByqB28nhvVw%3D A1995QW46700003
10. Yu H, Giai M, Diamandis EP, et al. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 1995; 55(10) 2104-2110. 7538047 1:CAS:528:DyaK2MXls1Oksrk%3D A1995QX36700021
11. Partin AW, Rodriguez R. The molecular biology, endocrinology, and phisiology of the prostate and seminal vesicles. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ. (eds) Campbell's Urology Saunders. Philadelphia 2002, pp 1279-1280.
12. Benjamin R. Neurologic complications of prostate cancer. Am Fam Physician 2002; 65(9): 1834-1840. 12018806
13. Agamanolis DP., http://www.akronchildrens.org/neuropathology/ CHAPTER_FOURTEEN.html
14. Schaller B, Merlo A, Kirsch E et al. Prostate-specific antigen in the cerebrospinal fluid leads to diagnosis of solitary cauda equina metastasis: A unique case report and review of the literature. Br J Cancer 1998; 77(12): 2386-2389. 9649164 1:STN:280:DyaK1czhtFCqug%3D%3D